---
run_id: halo-evidence-vs-diagnosis-validation-v12-criteria-prompted-no-sources-03
created: 2026-05-24
eval_type: contradiction-preservation
case_id: halo-evidence-vs-diagnosis-validation-v12
benchmark_version: halo-evidence-vs-diagnosis-validation-v12-v1
model_condition: criteria_prompted_no_sources
run_number: 3
model_name: gemma-4-31b-it-mlx:2
model_id: gemma-4-31b-it-mlx:2
model_snapshot: LM Studio MLX 8-bit model id lmstudio-community/gemma-4-31B-it-MLX-8bit; loaded_context_length 65536
runtime: LM Studio local OpenAI-compatible HTTP server; MLX runtime
provider: local
temperature: 0.7
top_p: 0.9
num_ctx: 65536
max_tokens: 2048
seed: 306
prompt_source: condition packet (criteria_prompted_no_sources) - frozen added material plus frozen Advisor prompt; see run-packet.md
prompt_sha256: 81621976eaf302301d88434e895bffe7f264ddbe9d86bbb0dd82120c2f65f2aa
source_packet: an abstract evidence-quality criteria reminder, then the frozen Advisor prompt; no source names, source cards, or case-specific answer hint - see run-packet.md
source_packet_sha256: eedcb93e6e1ac3648b936a1b5b4926243f86d4779861ecb7569972e407df3b14
condition_packet_sha256: eedcb93e6e1ac3648b936a1b5b4926243f86d4779861ecb7569972e407df3b14
output_file: model-outputs/criteria_prompted_no_sources-03.md
judge_model_id: pending - judge receipts recorded separately under judge-packet
judge_prompt_sha256: pending - judge receipts recorded separately under judge-packet
judge_independence: pending - judge receipts recorded separately under judge-packet
raw_model_output_public_safe: true
---

# Model Output - criteria_prompted_no_sources (run 03)

## Condition

Benchmark version `halo-evidence-vs-diagnosis-validation-v12-v1`, condition `criteria_prompted_no_sources`, run 3 of 8. Real local-model run: `gemma-4-31b-it-mlx:2` via lmstudio, seed 306, on the frozen condition packet.

## Output

**Recommendation: Run the Demand Cleanroom.**

The current growth metrics are contaminated by temporary pricing incentives and a sales pitch that sells a future roadmap rather than the current product's value. The rise in expansion bookings is likely a reflection of financial engineering (the bundle price) and anticipation of future features, not the utility of the existing tool. Because regional administrators are already seeking to remove the feature and public-sector users cannot justify its outputs, there is a high risk that the "strong quarter" is a lagging indicator of sales effort rather than a leading indicator of product-market fit. The Demand Cleanroom is the only intervention that isolates whether customers will pay for what exists today without the distortion of discounts or promises.

**Strongest reason against:** This approach risks short-term revenue. By removing bundle pricing and roadmap pitches, you may slow the current momentum of expansion bookings and extend sales cycles in the immediate term, which could be perceived as a failure by an executive team currently celebrating "commercial discipline."

**Observable evidence that would change my mind:** If the Case Evidence Review (which I am sacrificing) were to reveal that analysts are manually rewriting 90%+ of the plans but still renewing because the "starting point" saves them significant time, it would prove the product has foundational utility despite poor output quality. In that scenario, the problem is a usability gap rather than a demand gap, making the Adoption Quality Sprint or Case Evidence Review more valuable than testing price sensitivity.
